Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.90B | 20.87B | 21.74B | 20.23B | 21.24B | Gross Profit |
5.64B | 5.61B | 5.76B | 5.14B | 5.06B | EBIT |
1.31B | 1.30B | 1.42B | 1.10B | 873.00M | EBITDA |
2.11B | 2.11B | 2.10B | 2.04B | 1.58B | Net Income Common Stockholders |
771.00M | 950.00M | 1.02B | 994.00M | 660.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.82B | 3.14B | 2.76B | 3.98B | 2.92B | Total Assets |
23.35B | 20.56B | 19.67B | 19.35B | 18.67B | Total Debt |
2.19B | 68.00M | 78.00M | 89.00M | 98.00M | Net Debt |
-627.00M | -3.08B | -2.69B | -3.89B | -2.82B | Total Liabilities |
6.59B | 4.33B | 4.34B | 4.55B | 4.61B | Stockholders Equity |
16.59B | 16.21B | 15.32B | 14.78B | 14.05B |
Cash Flow | Free Cash Flow | |||
-128.00M | 458.00M | -541.00M | 1.00B | 856.00M | Operating Cash Flow |
1.71B | 1.97B | 807.00M | 1.56B | 1.60B | Investing Cash Flow |
-3.03B | -1.24B | -1.34B | -189.00M | -877.00M | Financing Cash Flow |
1.05B | -314.00M | -694.00M | -325.00M | -101.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥7.21B | 8.51 | 2.08% | 1.53% | -36.83% | ||
79 Outperform | ¥3.79B | 3.76 | 0.60% | 2.76% | 16.03% | ||
78 Outperform | ¥10.21B | 10.44 | 2.95% | 3.97% | 4.71% | ||
68 Neutral | ¥3.49B | 5.13 | 0.45% | 1.50% | -0.74% | ||
63 Neutral | ¥7.67B | 22.30 | 3.70% | 14.31% | 57.25% | ||
57 Neutral | ¥4.18B | 35.00 | 2.77% | -0.57% | -14.16% | ||
51 Neutral | $1.99B | -1.26 | -21.11% | 5.30% | 2.92% | -30.46% |